Health Sciences Group, Inc.
HESG · OTC
12/31/2012 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $5 |
| % Growth | 496% | -10.5% | -98.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $4 |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | 7% | 38.1% | 69.4% | 18.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $6 | $4 | $0 |
| SG&A Expenses | $0 | $7 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $2 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Expenses | $0 | $8 | $5 | $5 |
| Operating Income | -$0 | -$7 | -$5 | -$4 |
| % Margin | -15.2% | -12,440.6% | -6,766% | -70.9% |
| Other Income/Exp. Net | $0 | $2 | -$1 | -$2 |
| Pre-Tax Income | -$0 | -$6 | -$5 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$6 | -$10 | -$7 |
| % Margin | -15.2% | -9,560.7% | -15,552.6% | -138.3% |
| EPS | -0.029 | -0.25 | -0.78 | -0.76 |
| % Growth | 88.4% | 67.9% | -2.6% | – |
| EPS Diluted | -0.029 | -0.25 | -0.78 | -0.76 |
| Weighted Avg Shares Out | 2 | 25 | 14 | 11 |
| Weighted Avg Shares Out Dil | 2 | 25 | 14 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $3 | $1 | $1 |
| EBITDA | -$0 | -$5 | -$3 | -$2 |
| % Margin | -12.5% | -8,263.8% | -4,888.1% | -43.3% |